Senior Biotechnologist, Antibody Development - Lausanne

Updated: Aug 19

The company

A Swiss start-up dedicated to developing a novel, mechanism-based biologic treatment for Psoriasis. In collaboration with a leading research team at Lausanne University in Switzerland, they aim to advance the global understanding of autoinflammation mechanisms and their roles in Psoriasis, Inflammatory Bowel Disease, and Rheumatoid Arthritis.

The Role

Quality Assessment and Control:

Evaluate and validate the quality of work carried out by CDMOs.

Analyze complex datasets from CDMO activities to identify errors, inconsistencies, and areas for improvement.

Provide detailed feedback, corrective actions, and additional requirements based on data analysis.

Collaboration and Communication:

Maintain daily communication with company's global team via email and video conferences to align on project goals and updates.

Engage in regular, structured communication with CDMOs and Contract Research Organizations (CROs) to ensure project timelines are met and deliverables are of high quality.

Foster strong relationships with external partners to facilitate smooth collaboration and troubleshooting.

R&D Planning and Execution:

Lead the strategic planning and execution of the next stages of monoclonal antibody development, including the preclinical and clinical phases.

Ensure the use of the best techniques and methodologies available.

Oversee the selection and validation of high-quality raw materials, reagents, and technologies to optimize development processes.

We use cookies and similar technologies to enable services and functionality on our site and to understand your interaction with our service. By clicking on accept, you agree to our use of such technologies for marketing and analytics.See Privacy Policy